Lucintel Forecasts Cell Lysis & Disruption Market To Grow At A Cagr Of 7%-9%

By Author: Lucintel LLC
Total Articles: 4270
Comment this article

According to the recent study the cell lysis & disruption market is projected to grow at a CAGR of 7%-9% from 2020 to 2025. Growth in this market is primarily driven by increasing prevalence of diseases and disorders, increasing investment in research and development activities related to biotechnological process and academics, and growing focus on personalized medicines.
Browse XX figures / charts and XX tables in this 150-page report to understand trends, opportunities and forecast in cell lysis & disruption market by product (instruments (high-pressure homogenizers, sonicator, French press, microfluidizer, bead mill, and other instruments) and reagents & consumables (enzymes, detergent solutions (ionic detergent, nonionic detergent, and zwitterionic detergent), and kits & reagents)), cell type (mammalian cells, bacterial cells, yeast/algae/fungi, and plant cells), technique (reagent-based (detergent and enzymatic) and physical disruption (mechanical homogenization, ultrasonic homogenization, pressure homogenization, and temperature treatments)), application (protein isolation, downstream processing, ...
... cell organelle isolation, and nucleic acid isolation), end use (academic & research institutes, hospitals & diagnostic labs, cell banks, and pharmaceutical & biotechnology companies), and region (North America, Europe, Asia Pacific, and Rest of the World).
Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/cell-lysis-aand-disruption-marke.aspx
“Reagents and consumables market is expected to remain the largest segment during the forecast period.”
Based on product, the cell lysis & disruption market is segmented into instruments (high-pressure homogenizers, sonicator, french press, microfluidizer, bead mill, and other instruments) and reagents and consumables (enzymes, detergent solutions (ionic detergent, nonionic detergent, and zwitterionic detergent), and kits & reagents). Lucintel forecasts that the reagents and consumables market is expected to remain the largest segment during the forecast period due to rising prevalence of diseases and increasing funding of cell-based research.
“Within the cell lysis & disruption market, the academic & research institutes segment is expected to remain the largest end use.”
Based on end use, the academic & research institutes segment is expected to witness the largest segment over the forecast period due to increasing research activities related to molecular biology and bioprocess techniques.
“North America will dominate the cell lysis & disruption market in near future.”
North America is expected to be the largest region over the forecast period over the forecast period due to increasing government initiatives related to research and development and rising private and public investments for drug discovery and developing treatment of complicated and rare diseases in the region.
Download Brochure of this report by clicking on https://www.lucintel.com/cell-lysis-aand-disruption-marke.aspx
Major players of cell lysis & disruption market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Thermo Fisher Scientific, Merck, Roche, Qiagen, B&D, Danaher, Bio-Rad Laboratories, Miltenyi Biotec, Claremont BioSolutions, and Microfluidics International are among the major cell lysis & disruption providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/cell-lysis-aand-disruption-marke.aspx or helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Minimally Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

Endoscopy Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx

Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx

Urology Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx

Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx